ALGAE
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw mat… Read more
ALGAE (ALGAE) - Total Liabilities
Latest total liabilities as of June 2025: €16.64 Million EUR
Based on the latest financial reports, ALGAE (ALGAE) has total liabilities worth €16.64 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ALGAE - Total Liabilities Trend (2011–2024)
This chart illustrates how ALGAE's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ALGAE Competitors by Total Liabilities
The table below lists competitors of ALGAE ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vranken-Pommery Monopole Société Anonyme
PA:VRAP
|
France | €927.49 Million |
|
NMC Resource Corporation
V:NRC
|
Canada | CA$105.41K |
|
Dinamik Isi Makina Yalitim Malzemeleri Sanayi ve Ticaret AS
IS:DNISI
|
Turkey | TL343.85 Million |
|
Aclara Resources Inc
PINK:ARAAF
|
USA | $7.81 Million |
|
Luminescence Technology Corp.
TWO:6729
|
Taiwan | NT$51.85 Million |
|
Soc Centrale Bois Scieries Manche SA
PA:CBSM
|
France | €239.88 Million |
|
Infinite Finance Co. Ltd.
TW:6958
|
Taiwan | NT$69.94 Billion |
|
Shapir Engineering Industry
TA:SPEN
|
Israel | ILA12.93 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down ALGAE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.98 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ALGAE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ALGAE (2011–2024)
The table below shows the annual total liabilities of ALGAE from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €18.39 Million | -5.22% |
| 2023-12-31 | €19.40 Million | +24.67% |
| 2022-12-31 | €15.56 Million | +12.15% |
| 2021-12-31 | €13.87 Million | -35.71% |
| 2020-12-31 | €21.58 Million | +35.15% |
| 2019-12-31 | €15.97 Million | +28.56% |
| 2018-12-31 | €12.42 Million | -3.06% |
| 2017-12-31 | €12.81 Million | +34.79% |
| 2016-12-31 | €9.51 Million | +5.90% |
| 2015-12-31 | €8.98 Million | +95.34% |
| 2014-12-31 | €4.59 Million | +54.35% |
| 2013-12-31 | €2.98 Million | -5.73% |
| 2012-12-31 | €3.16 Million | +213.60% |
| 2011-12-31 | €1.01 Million | -- |